Cite
[Prophylaxis of venous thromboembolism in medical patients: from medical decision tools to the use of low molecular weight heparin].
MLA
Thilly, N., et al. “[Prophylaxis of Venous Thromboembolism in Medical Patients: From Medical Decision Tools to the Use of Low Molecular Weight Heparin].” Therapie, vol. 53, no. 6, Nov. 1998, pp. 579–86. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=10070237&authtype=sso&custid=ns315887.
APA
Thilly, N., Pierson, H., Collard, C., Lecompte, T., & Dufay, E. (1998). [Prophylaxis of venous thromboembolism in medical patients: from medical decision tools to the use of low molecular weight heparin]. Therapie, 53(6), 579–586.
Chicago
Thilly, N, H Pierson, C Collard, T Lecompte, and E Dufay. 1998. “[Prophylaxis of Venous Thromboembolism in Medical Patients: From Medical Decision Tools to the Use of Low Molecular Weight Heparin].” Therapie 53 (6): 579–86. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=10070237&authtype=sso&custid=ns315887.